Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹130/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Glimtype MP1 Tablet is a bi-layered formulation that combines three potent antidiabetic agents: Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg). This combination works synergistically to effectively control blood sugar levels in individuals with type 2 diabetes mellitus (T2DM).
Diabetes is a chronic condition that requires multifaceted treatment strategies to maintain optimal blood glucose levels and reduce the risk of complications. Gimtype MP1 helps regulate glucose metabolism by stimulating insulin secretion, improving insulin sensitivity, and reducing hepatic glucose production, making it a reliable choice for diabetes management.
✔ Glimepiride (1mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose levels. ✔ Metformin (500mg): A biguanide that reduces glucose production in the liver, enhances insulin sensitivity, and improves glucose uptake in muscles. ✔ Pioglitazone (15mg): A thiazolidinedione that enhances insulin sensitivity by acting on peripheral tissues, leading to better glucose utilization and reduced insulin resistance.
May include hypoglycemia (low blood sugar), nausea, dizziness, weight gain, edema, gastrointestinal discomfort, or mild liver enzyme elevation. Seek medical advice if symptoms persist.
Used in the management of type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control.
Take this medication exactly as prescribed by a healthcare professional. Regular blood sugar monitoring is essential to avoid hypoglycemia or hyperglycemia. Follow a healthy diet and exercise routine for optimal diabetes management.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Glimepiride 1mg + Metformin 500mg + Pioglitazone 15mg Bi-Layered Tablets
Composition : Glimepiride (1mg) + Metformin (500mg) SR Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (1000mg) SR Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (500mg) SR Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Glimepiride (4mg) + Metformin (1000mg) SR Bilayered Smart Tablet
Composition : Glimepiride (2mg) Tablet
Composition : Glimepiride (1mg) Tablet
Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This triple combination has strong demand in the anti-diabetic and chronic care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced diabetes management portfolios.
Medical distributors and agencies can benefit from consistent demand for management of Type 2 Diabetes Mellitus, insulin resistance, and uncontrolled blood sugar requiring combination therapy. Glimepiride 1mg stimulates insulin secretion from the pancreas Metformin 500mg reduces hepatic glucose production and improves insulin sensitivity Pioglitazone improves peripheral insulin sensitivity in muscle and fat tissue This triple mechanism provides strong and balanced glycemic control, strengthening a reliable diabetes-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glimepiride + Metformin + Pioglitazone Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high diabetic patient demand, strong physician prescriptions, long-term recurring sales, stable chronic-care market, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.